Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001764013-26-000048
Filing Date
2026-04-09
Accepted
2026-04-09 16:26:52
Documents
1
Period of Report
2026-04-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1775766410.html 4  
1 FORM 4 wk-form4_1775766410.xml 4 5975
  Complete submission text file 0001764013-26-000048.txt   7522
Mailing Address C/O EARGO, INC. 2665 NORTH FIRST STREET, SUITE 300 SAN JOSE CA 95134
Business Address
Hughes Douglas J. (Reporting) CIK: 0001710863 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38906 | Film No.: 26851954

Mailing Address 1000 PARK FORTY PLAZA DURHAM NC 27713
Business Address 1000 PARK FORTY PLAZA DURHAM NC 27713 917-410-3120
Immunovant, Inc. (Issuer) CIK: 0001764013 (see all company filings)

EIN.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)